MedTrace Logo

Pharmacogenomics and Effective Treatment With Clopidogrel

NCT01611545 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2015-06-11

No results posted yet for this study

Summary

The aim of this biospecimen repository is to evaluate an individual's genotype, identify the variances, and understand how they relate to treatment with clopidogrel.

Conditions

  • Pharmacogenomics and Cardiovascular Events

Interventions

GENETIC

Pharmacogenomics

Utilizing pharmacogenomics to determine the most effective treatment

Sponsors & Collaborators

  • Avera Heart Hospital of South Dakota

    collaborator UNKNOWN

  • North Central Heart Institute

    collaborator UNKNOWN

  • Avera McKennan Hospital & University Health Center

    lead OTHER

Principal Investigators

  • Gareth Davies, PhD · Avera McKennan Hospital & University Health Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2015-01-31
Completion
2015-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01611545 on ClinicalTrials.gov